IL20RA and colorectal cancer: JQ1 and iBET-151 can inhibit colorectal cancer development, metastasis, and IL-20RA expression, demonstrating that IL-20RA, activated by super enhancers, affects colorectal cancer cell proliferation and immune escape [83].